From: Stem cell therapy in sensorineural hearing loss: a systematic review
Author (year) | Species | Cell type; source; (origin) | Delivery; timing relative to injury | Hearing function | MSC recovery and survival; immune |
---|---|---|---|---|---|
Pandit (2011) [7] | A/J mice | Olfactory stem cells; human; xenogeneic | Direct into cochlea; | ABR | Immune response |
4 wks after; | |||||
Zhou (2011) [8] | BALB/c mice | Adipose-derived stem cells; human; xenogeneic | Intraperitoneally; | ABR | Immune response |
2 wks after; | |||||
Choi, B (2012) [9] | Sprague Dawley rat | Bone marrow; human; xenogeneic | Infusion via tail vein; | ABR | Immune response |
48–96 h after; | |||||
Choi, M (2012) [10] | C57BL/6Â J mice | Umbilical cord blood; human; xenogeneic | Infusion via brachial vein; | ABR & DPOE | MSC recovery and survival |
3Â days after; | |||||
Kasagi (2013) [11] | C57BL/6Â J mice | Bone marrow; mice; allogenic | into ampulla of the semicircular canal; | ABR | N/A |
Not reported; | |||||
Yoo (2015) [12] | BALB/c mice | Adipose-derived cells; human; xenogeneic | Intraperitoneally; | ABR | N/A |
2Â weeks after; | |||||
Kil (2016) [13] | Guinea Pig | Placental-derived cells; human; xenogeneic | IV via brachial vein; | ABR & DPOE | MSC recovery and engraftment |
3Â days after; | |||||
Ma (2016) [14] | Pigs | Umbilical cord blood; human; xenogeneic | Into the subarachnoid cavity; | ABR | MSC recovery and engraftment |
N/A; | |||||
Chen (2018) [15] | CBA/CaJ mice | Limbal cells from corneal transplant; human; xenogeneic | Injection around cochlear nerve; | ABR & DPOE | MSC recovery and engraftment |
2Â weeks after; |